Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jeffbas who wrote (5216)	10/30/1998 9:52:00 AM
From: Joe Dancy	Read Replies (1) of 78534

I've recently invested in Pharmerica (DOSE) - providing pharmaceutical services to institutions- it has a price to earnings ratio of less than 10, a price to book ratio of 0.7, a current ratio over three, and a price to sales ratio of 0.4. Revenues have grown strongly over the last few years as a result of acquisitions and internal growth. Long term I like the concept and sector. Short term I wouldn't expect much. Write up at bizfn.com Joe

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next